Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Virtual reality goggles may help hospitalized seniors sleep soundly

NCT ID NCT07499245

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether watching calming 360-degree videos through virtual reality goggles can improve sleep quality and comfort for older adults (60+) staying in the hospital. Sixty participants will be randomly assigned to either watch the videos for 20 minutes each night or receive usual care. The goal is to see if this simple, drug-free approach can help seniors sleep better and feel more at ease during their hospital stay.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Older adults willing to participate in the study * Being 60 years of age or older * Not having been diagnosed with Parkinson's disease or a psychiatric disorder, not having cognitive impairment, and being able to communicate * Absence of a sleep apnea diagnosis * Scoring 24 or higher on the Standardized Mini Mental Test * The participant stated that her average nightly sleep duration is less than 5 hours * Avoid using medications that may affect sleep (acetylcholinesterase inhibitors, beta-blockers, diuretics, phenytoin, theophylline, benzodiazepines, etc.) * Hospital stay must be at least 3 days * Avoid smoking in the last 15 minutes before a session and avoid using caffeine stimulants (tea/coffee/chocolate/cola etc.) exceeding 1.4 mg/kg in the 10 hours prior. * Lack of photosensitivity * Eye disease and absence of contact lenses Exclusion Criteria: * Those unwilling to participate in the study * Those who are not 60 years of age or older * Patients diagnosed with Parkinson's disease and psychiatric disorders, who have cognitive impairment and are unable to communicate * Having a diagnosis of sleep apnea * Those who score below 24 on the Standardized Mini Mental Test * Those who stated that their average nightly sleep duration is more than 5 hours * Those who use medication (acetylcholinesterase inhibitor, beta blocker, diuretic, phenytoin, theophylline, benzodiazepine etc.) that can affect sleep * Hospital stay of 3 days or less * Smoking a cigarette in the last 15 minutes before a session and using caffeine stimulants (tea/coffee/chocolate/cola etc.) above 1.4 mg/kg 10 hours prior * Having photosensitivity * Older adults with eye disease and contact lenses

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Older adults (65 years and older) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Kafkas University, Faculty of Health Sciences Department of Nursing

    Kars, 36100, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.